Impossible Objects
Impossible Objects Raises $40M Series B for Industrial 3D Printing
Impossible Objects announced $40M in Series B financing on September 11, 2026. Impossible Objects raised a $40 million Series B led by Inflection Equity to scale its Composite-Based Additive Manufacturing (CBAM) technology and meet growing customer demand.
Round details
The financing includes backing from Inflection Equity, Aaron Wealth Management, OCA Ventures, Impact Capital, Excell Partners. The company did not publish a valuation with the announcement.
- Round: Series B
- Capital announced: $40M
How the company plans to use the capital
Impossible Objects will use the financing to increase production of its industrial additive manufacturing systems, expand customer deployments, and build out the service and commercial organization needed to support a growing installed base.
Why this matters for GTM teams
Impossible Objects says its CBAM technology can produce parts for applications traditionally served by processes such as CNC machining and injection molding, and its announcement cites growing adoption across aerospace, defense and advanced manufacturing.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Impossible Objects Series B announcement.
Company Info
Investors (5)
Share
Related Reports
Infisical Raises $40M Series B for AI Agent Security Infrastructure
Infisical raised a $40 million Series B at a $600 million valuation, led by Elad Gil, to expand security infrastructure for AI agents.
Vera Health Raises $28.5M Series A for Clinical AI Search
Vera Health raised a $28.5 million Series A led by Threshold Ventures to further develop its clinical evidence infrastructure and expand into additional healthcare markets.
Omnichat Raises US$10M Series A for Agentic Customer Experience Platform
Omnichat raised a US$10 million Series A led by Openspace Capital to scale its agentic AI platform, deepen R&D on Omni AI Agents and expand globally.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free